Literature DB >> 2647471

Relaxin stimulates prolactin secretion from anterior pituitary cells.

M A Sortino1, M J Cronin, P M Wise.   

Abstract

The anterior pituitary has recently been implicated as a relaxin target issue because of the cAMP elevation after relaxin treatment. We attempted to correlate this finding with an endocrine response to relaxin in rats. Anterior pituitary cells were enzymatically dispersed and subjected to the reverse hemolytic plaque assay. PRL secretion was significantly stimulated 1.31-fold by human relaxin at the lowest concentration studied (30 pM) and maximally stimulated 1.65-fold at 0.3 nM relaxin. Antibodies directed against relaxin inhibited this effect, as did the PRL inhibitory hormone, dopamine. In contrast to the response of PRL cells, there was no effect or a slight inhibition of LH release after incubation with relaxin. In conclusion, we propose that one of the pituitary cell types responsive to relaxin in culture is the PRL-secreting mammotroph.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647471     DOI: 10.1210/endo-124-4-2013

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Central administration of porcine relaxin stimulates drinking behaviour in rats: an effect mediated by central angiotensin II.

Authors:  A J Summerlee; G F Robertson
Journal:  Endocrine       Date:  1995-05       Impact factor: 3.633

2.  Relaxin has a minor role in rat mammary gland growth and differentiation during pregnancy.

Authors:  L Kass; J G Ramos; H H Ortega; G S Montes; L E Bussmann; E H Luque; M Muñoz de Toro
Journal:  Endocrine       Date:  2001-08       Impact factor: 3.633

3.  The cardiovascular effects of porcine relaxin in Brattleboro rats.

Authors:  L J Parry; B C Wilson; R S Poterski; A J Summerlee
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

4.  Luteal and hypophyseal expression of the canine relaxin (RLN) system during pregnancy: Implications for luteotropic function.

Authors:  Marta Nowak; Alois Boos; Mariusz P Kowalewski
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.